Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...

Discover why pharma sector leaders and AI innovation may drive the S&P 500 to 9,000 by 2026. Explore top stocks, growth ...

What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income ...

Asahi Kasei Pharma Corporation has announced plans to relocate its R&D hub from Izunokuni City, Shizuoka Prefecture (Ohito) ...

Check out a month-by-month breakdown of the major events affecting the pharma and medical marketing industries in 2025.

The deal announced Friday tacks on to similar reduced price agreements the Trump administration has made with five other ...

Large pharmaceutical companies are entering a period of renewed relevance as therapeutic innovation accelerates, particularly ...

Traws Pharma reports interim Phase 2 data showing ratutrelvir performed comparably to Paxlovid in mild-to-moderate COVID-19 ...

Ratutrelvir shows a differentiated profile versus PAXLOVID™ with fewer adverse events and no viral reboundsActivity shown in Paxlovid®-ineligible ...

Martin Shkreli, the notorious former CEO of Turing Pharmaceuticals and convicted securities fraudster, will still be banned from working in the pharmaceutical industry after a federal appeals court in ...